O
Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
451
Ingevity
NGVT
$2.21B
|
IZ
Ian Zaffino
| $60.74 | $50 |
18%
downside
| Outperform |
1 Aug ‘24
1 year ago |
|
452
Community Health Systems
CYH
$415M
|
MW
Michael Wiederhorn
| $2.96 | $5 |
69%
upside
| Outperform |
25 Jul ‘24
1 year ago |
|
453
Integer Holdings
ITGR
$3.72B
|
SK
Suraj Kalia
| $106.22 | $135 |
27%
upside
| Outperform |
16 Jul ‘24
1 year ago |
|
454
CalciMedica
CALC
$43.2M
|
LG
Leland Gershell
| $3.09 | $20 |
547%
upside
| Outperform |
10 Jul ‘24
1 year ago |
|
|
SPMC
455
Sound Point Meridian Capital, Inc.
SPMC
|
MP
Mitchel Penn
| $18.11 | $21 |
16%
upside
| Outperform |
9 Jul ‘24
1 year ago |
|
456
Nike
NKE
$110B
|
BN
Brian Nagel
| $74.15 | $120 |
62%
upside
| Outperform |
28 Jun ‘24
1 year ago |
|
457
AutoZone
AZO
$71B
|
BN
Brian Nagel
| $4,242.88 | $2,600 |
39%
downside
| Perform |
26 Jun ‘24
1 year ago |
|
458
Adverum Biotechnologies
ADVM
$74.3M
|
FB
Francois Brisebois
| $3.54 | $25 |
606%
upside
| Outperform |
25 Jun ‘24
1 year ago |
|
459
MoonLake Immunotherapeutics
MLTX
$3.88B
|
AA
Andreas Argyrides
| $61.12 | $104 |
70%
upside
| Outperform |
25 Jun ‘24
1 year ago |
|
460
Clearside Biomedical
CLSD
$26.4M
|
AA
Andreas Argyrides
| $0.3361 | $5 |
1,388%
upside
| Outperform |
25 Jun ‘24
1 year ago |
|
461
Gossamer Bio
GOSS
$605M
|
AA
Andreas Argyrides
| $2.66 | $9 |
238%
upside
| Outperform |
25 Jun ‘24
1 year ago |
|
462
Editas Medicine
EDIT
$251M
|
JO
Jay Olson
| $2.79 | $12 |
330%
upside
| Perform |
18 Jun ‘24
1 year ago |
|
463
Simulations Plus
SLP
$285M
|
FB
Francois Brisebois
| $14.16 | $65 |
359%
upside
| Outperform |
13 Jun ‘24
1 year ago |
|
|
CLLS
464
Cellectis
CLLS
$275M
|
HS
Hartaj Singh
| $2.74 | $10 |
265%
upside
| Outperform |
12 Jun ‘24
1 year ago |
|
465
Aramark
ARMK
$10.1B
|
IZ
Ian Zaffino
| $38.32 | $39 |
2%
upside
| Outperform |
12 Jun ‘24
1 year ago |
|
466
Microsoft
MSFT
$3.7T
|
TH
Timothy Horan
| $498.20 | $500 |
0%
upside
| Outperform |
7 Jun ‘24
1 year ago |
|
467
Catalyst Pharmaceutical
CPRX
$2.46B
|
LG
Leland Gershell
| $20.08 | $29 |
44%
upside
| Outperform |
6 Jun ‘24
1 year ago |
|
468
Xylem
XYL
$34.1B
|
BB
Bryan Blair
| $140.03 | $152 |
9%
upside
| Outperform |
31 May ‘24
1 year ago |
|
469
Asana
ASAN
$3.25B
|
GI
George Iwanyc
| $13.77 | $23 |
67%
upside
| Outperform |
31 May ‘24
1 year ago |
|
470
Biomea Fusion
BMEA
$108M
|
HS
Hartaj Singh
| $1.81 | $60 |
3,215%
upside
| Outperform |
30 May ‘24
1 year ago |
|
471
Box
BOX
$4.8B
|
GI
George Iwanyc
| $33.11 | $35 |
6%
upside
| Outperform |
29 May ‘24
1 year ago |
|
472
Ametek
AME
$43.6B
|
CG
Christopher Glynn
| $188.67 | $200 |
6%
upside
| Outperform |
22 May ‘24
1 year ago |
|
473
Allogene Therapeutics
ALLO
$253M
|
MB
Mark Breidenbach
| $1.14 | $13 |
1,040%
upside
| Outperform |
21 May ‘24
1 year ago |
|
474
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.45B
|
NK
Noah Kaye
| $27.78 | $48 |
73%
upside
| Outperform |
16 May ‘24
1 year ago |
|
475
Cisco
CSCO
$264B
|
IK
Ittai Kidron
| $66.88 | $58 |
13%
downside
| Outperform |
16 May ‘24
1 year ago |
|